EPIGENETIC READER INHIBITOR APABETALONE (RVX-208) COUNTERS PROINFLAMMATORY HYPERACTIVATION OF CD14+ MONOCYTES FROM PATIENTS WITH TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE

Category Primary study
JournalJ. Am. Coll. Cardiol.
Year 2020
This article has no abstract
Epistemonikos ID: 5214448221b4330f563a6bd0cf57a57675c23be8
First added on: May 08, 2021